tend to disagree GD..I don't feel that costs have sky rocketed..I'll try and explain my view..whilst ignoring the placement implications
...net operating cash flow NOCF) this quarter worsened by around $1.5M over the previous quarter
.....part of that was due to less cash being received approx $400K compared too the previous quarter (one might have expected more but this is only a timing issue) as we know revenue for the period was $2.5M of which CardioCel contributed $1M, so another $600k+ in cash is still to flow in (this excludes any cash which may be owing for longer than three months)..these $$$ are coming...
....throw in around an additional $850K in working capital increasing the balance of stocks of CardioCel (which is also an asset of the company that will be sold at a much higher price)...this was obviously needed to meet future demand for CardioCel...this is not wasted $$$
...R&D has increased by $150K compared to the previous quarter ..needed I would assume..this costs is fully recoverable...this is not wasted $$$
...that leaves staff costs which increased by $202K over the quarter....a break up of this mayhelp...these may or not be wasted $$$ but no-one here can determine this
..imo, the claim that costs have sky rocketed falls short , but happy to be picked apart..
- Forums
- ASX - By Stock
- AVR
- Quarterly
Quarterly, page-137
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.48 |
Change
-0.020(0.17%) |
Mkt cap ! $242.6M |
Open | High | Low | Value | Volume |
$11.50 | $11.50 | $10.91 | $152.9K | 13.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 257 | $11.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 4416 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 257 | 11.100 |
1 | 631 | 11.000 |
1 | 150 | 10.920 |
1 | 46 | 10.910 |
1 | 48 | 10.900 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 4416 | 1 |
11.830 | 500 | 1 |
11.850 | 164 | 1 |
11.900 | 1000 | 1 |
12.100 | 500 | 1 |
Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online